{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:47:17Z","timestamp":1789001237924,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.aohep.2025.102147","type":"journal-article","created":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T03:31:01Z","timestamp":1761363061000},"page":"102147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Reevaluating the clinical course of AMA-positive patients with normal liver enzymes: A large retrospective cohort study"],"prefix":"10.1016","volume":"31","author":[{"given":"Ahmad","family":"Yahia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fadi Abu","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9865-0785","authenticated-orcid":false,"given":"Mifleh","family":"Tatour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7731-118X","authenticated-orcid":false,"given":"Rawi","family":"Hazzan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.aohep.2025.102147_bib0001","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/hep.510250507","article-title":"Comparison of the clinical features and course of antimitochondrial antibody-positive and antimitochondrial antibody-negative primary biliary cirrhosis","volume":"25","author":"Invernizzi","year":"1997","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.aohep.2025.102147_bib0002","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/hep.1840090311","article-title":"Immunization of experimental animals with dihydrolipoamide acetyltransferase, as a purified recombinant polypeptide, generates mitochondrial antibodies but not primary biliary cirrhosis","volume":"9","author":"Krams","year":"1989","journal-title":"Hepatology"},{"issue":"10003","key":"10.1016\/j.aohep.2025.102147_bib0003","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(15)00154-3","article-title":"Primary biliary cirrhosis","volume":"386","author":"Carey","year":"2015","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.aohep.2025.102147_bib0004","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMra043898","article-title":"Primary biliary cirrhosis","volume":"353","author":"Kaplan","year":"2005","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.aohep.2025.102147_bib0005","first-page":"223","article-title":"Primary biliary cirrhosis: natural history","volume":"73","author":"Jr","year":"1980","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1016\/j.aohep.2025.102147_bib0006","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/0016-5085(90)91091-J","article-title":"Diminished survival in asymptomatic primary biliary cirrhosis. A prospective study","volume":"98","author":"Balasubramaniam","year":"1990","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.aohep.2025.102147_bib0007","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1053\/jhep.2000.18714","article-title":"Fine specificity of T cells reactive to human PDC-E2 163-176 peptide","volume":"32","author":"Shigematsu","year":"2000","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.aohep.2025.102147_bib0008","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1053\/jhep.2001.26514","article-title":"Detection of AMA in AMA-negative patients with PBC using recombinant autoantigens","volume":"34","author":"Miyakawa","year":"2001","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102147_bib0009","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/hep.510260103","article-title":"Does AMA status affect response to treatment in PBC?","volume":"26","author":"Kim","year":"1997","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.aohep.2025.102147_bib0010","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1053\/jhep.2001.23783","article-title":"Heterogeneous AMA response to pyruvate dehydrogenase complex","volume":"33","author":"Migliaccio","year":"2001","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.aohep.2025.102147_bib0011","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1053\/gast.2000.20197","article-title":"Epidemiology and natural history of PBC in a U.S. community","volume":"119","author":"Kim","year":"2000","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.aohep.2025.102147_bib0012","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00432479","article-title":"Staging of chronic non-suppurative destructive cholangitis","volume":"379","author":"Ludwig","year":"1978","journal-title":"Virchows Arch A Pathol Anat Histol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102147_bib0013","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1007\/s00535-004-1312-2","article-title":"Significance of AMA prevalence in healthy subjects","volume":"39","author":"Onji","year":"2004","journal-title":"J Gastroenterol"},{"issue":"3","key":"10.1016\/j.aohep.2025.102147_bib0014","first-page":"405","article-title":"The role of mitochondrial antigens in PBC and systemic autoimmune diseases","volume":"61","author":"Colapietro","year":"2021","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.aohep.2025.102147_bib0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2019.01.005","article-title":"Histologically proven AMA-positive primary biliary cholangitis but normal serum alkaline phosphatase: is alkaline phosphatase truly a surrogate marker?","volume":"99","author":"Sun","year":"2019","journal-title":"J Autoimmun"},{"issue":"8","key":"10.1016\/j.aohep.2025.102147_bib0016","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/hepr.12809","article-title":"Positive antimitochondrial antibody but normal serum alkaline phosphatase levels: could it be primary biliary cholangitis?","volume":"47","author":"Berdichevski","year":"2017","journal-title":"Hepatol Res"},{"issue":"3","key":"10.1016\/j.aohep.2025.102147_bib0017","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/hep.21749","article-title":"Increased prevalence of antimitochondrial antibodies in first-degree relatives of patients with primary biliary cirrhosis","volume":"46","author":"Lazaridis","year":"2007","journal-title":"Hepatology"},{"issue":"21","key":"10.1016\/j.aohep.2025.102147_bib0018","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1056\/NEJM198905253202104","article-title":"Detection of autoantibodies to recombinant mitochondrial proteins in patients with primary biliary cirrhosis","volume":"320","author":"Van de Water","year":"1989","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.aohep.2025.102147_bib0019","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.jhep.2017.03.022","article-title":"EASL Clinical Practice Guidelines: the diagnosis and management of cholestatic liver diseases","volume":"67","year":"2017","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.aohep.2025.102147_bib0020","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/hep.28859","article-title":"Large-scale characterization study of patients with antimitochondrial antibodies but non-established primary biliary cholangitis","volume":"65","author":"Dahlqvist","year":"2017","journal-title":"Hepatology"},{"issue":"9039","key":"10.1016\/j.aohep.2025.102147_bib0021","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(96)04410-8","article-title":"Natural history of early primary biliary cirrhosis","volume":"348","author":"Metcalf","year":"1996","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.aohep.2025.102147_bib0022","doi-asserted-by":"crossref","first-page":"474","DOI":"10.3350\/cmh.2024.0416","article-title":"Prediction of primary biliary cholangitis among the health check-up population with anti-mitochondrial M2 antibody positivity","volume":"31","author":"Li","year":"2025","journal-title":"Clin Mol Hepatol"},{"issue":"2","key":"10.1016\/j.aohep.2025.102147_bib0023","first-page":"282","article-title":"Evaluation of patients with positive anti-mitochondrial antibody and normal alkaline phosphatase levels for primary biliary cholangitis","volume":"87","author":"Ellez","year":"2024","journal-title":"Acta Gastroenterol Belg"},{"key":"10.1016\/j.aohep.2025.102147_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2020.102578","article-title":"Primary biliary cholangitis with normal alkaline phosphatase: a neglected clinical entity challenging current guidelines","volume":"116","author":"Terziroli Beretta-Piccoli","year":"2021","journal-title":"J Autoimmun"},{"issue":"11","key":"10.1016\/j.aohep.2025.102147_bib0025","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1002\/hep4.2067","article-title":"The future risk of primary biliary cholangitis (PBC) is low among patients with incidental anti-mitochondrial antibodies but without baseline PBC","volume":"6","author":"Duan","year":"2022","journal-title":"Hepatol Commun"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1665268125003722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T08:54:21Z","timestamp":1780649661000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1665268125003722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1665268125003722"],"URL":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102147","relation":{},"ISSN":["1665-2681"],"issn-type":[{"value":"1665-2681","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reevaluating the clinical course of AMA-positive patients with normal liver enzymes: A large retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aohep.2025.102147","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"102147"}}